INVIVYD, INC.

Profile

Company Names

INVIVYD, INC.
ADAGIO THERAPEUTICS, INC.

Addresses

1601 TRAPELO ROAD, SUITE 178, WALTHAM, MA 02451

303 WYMAN STREET, SUITE 300, WALTHAM, MA 02451

Phone Numbers

(781) 819-0080
(781) 248-2771

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$489,149,272.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-11-15 
$23,749,998.00 
$23,749,998.00 
$0.00 
Equity 
3
2021-04-16 
$335,499,458.00 
$335,499,458.00 
$0.00 
Equity 
2
2020-10-30 
$79,999,816.00 
$79,999,816.00 
$0.00 
Equity 
1
2020-07-09 
$49,900,000.00 
$49,900,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JILL 
 
ANDERSEN 
EXECUTIVE OFFICER
TAMSIN 
 
BERRY 
DIRECTOR
PHILIP 
 
CHASE 
DIRECTOR
PHILIP 
T. 
CHASE 
DIRECTOR
LYNN 
 
CONNOLLY 
EXECUTIVE OFFICER
REBECCA 
 
DABORA 
EXECUTIVE OFFICER
FRED 
 
DRISCOLL 
EXECUTIVE OFFICER
TILLMAN 
U. 
GERNGROSS 
EXECUTIVE OFFICER, DIRECTOR
HALLEY 
 
GILBERT 
EXECUTIVE OFFICER
DAVID 
 
HERING 
EXECUTIVE OFFICER, DIRECTOR
ELLIE 
 
HERSHBERGER 
EXECUTIVE OFFICER
TOM 
 
HEYMAN 
DIRECTOR
ERIC 
 
KIMBLE 
EXECUTIVE OFFICER
CHRISTINE 
 
LINDENBOOM 
DIRECTOR
CLIVE 
A. 
MEANWELL 
DIRECTOR
RENE 
 
RUSSO 
DIRECTOR
LAURA 
 
WALKER 
EXECUTIVE OFFICER
MICHAEL 
S. 
WYZGA 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-11-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#